作者:
Kim,K.B. [1]
;
Prieto,V. [2]
;
Joseph,R.W. [3]
;
Diwan,A.H. [4]
;
Gallick,G.E. [5]
;
Papadopoulos,N.E. [6]
;
Bedikian,A.Y. [7]
;
Camacho,L.H. ;
Hwu,P. ;
Ng,C.S. ;
Wei,W. ;
Johnson,M.M. ;
Wittemer,S.M. ;
Vardeleon,A. ;
Reckeweg,A. ;
Colevas,A.D.
作者单位:
Department of Diagnostic Radiology, MD Anderson Cancer Center, University of Texas, Houston, TX
[1]
Merck KGaA, Darmstadt, Germany
[2]
Department of Biostatistics, MD Anderson Cancer Center, University of Texas, Houston, TX, United
[3]
Department of Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, 1515
[4]
Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, United States
[5]
Department of Pathology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States
[6]
Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, University of Texas
[7]
发布时间
2013-11-20